Selling the Dendreon business will help Valeant simplify and focus on ... Register now to create your own custom streaming stock watchlist. …
Valeant
Basically, if Valeant would have sold Dendreon in May of last year for the same $820 million ... I have no business relationship with any company whose stock is mentioned in this article.
Valeant
Valeant had bought Dendreon two years ago for $400 million ...
asset sales
Its skin care line is going to L’Oreal SA (ADR) (OTCMKTS:LRLCY), and its equity interest in Dendreon — which produced prostate ... Heading into …
Valeant Pharmaceuticals
It would seem that Valeant, which has seen its stock price rise around 9% in 30 days ... Valeant said it entered into an agreement to sell all the outstanding equity interest in Dendreon Pharmaceuticals to the China-based …
short sellers
The seemingly endless stream of bad news caused the stock to tumble more than 85% in 2016; however, management's news today could …
Valeant Pharmaceuticals
Merck is a Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks ... The other agreement will see Valeant selling off the outstanding equity interests in Dendreon Pharmaceuticals to the Sanpower …
Merck
Shares of the company have plunged more than 90 percent from the stock’s high of $257 in July 2015. The sale of Canada-based Valeant’s skincare …
Valeant stock
Investors in Dendreon Corp (NASD: DNDN) saw new options begin trading today, for the November 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options …